New treatment could reverse hair loss caused by an autoimmune skin disease
Science Daily
Researchers developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss. The microneedle..
Alopecia areata
News and Video Search Results
News coverage
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
-
ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
GlobeNewswire
-
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
GlobeNewswire
0 shares
1 views
You might like
Alopecia areata media coverage
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
GlobeNewswire
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage,..
-
Bestqool proves the effectiveness and safety of its red light therapy device with a professional third-party Report
GlobeNewswire
-
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
-
Alopecia drug approved for use in NHS in Scotland
BBC News
-
Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
GlobeNewswire
Advertisement
More coverage
-
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
GlobeNewswire
-
Apogee Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases, Exceeding its Trial Objectives Ahead of Sc
GlobeNewswire